These results also strongly demonstrate that NGFR maintains the ability of MIC cells to sustain stemness-like phenotype (sphere formation) and proliferation by mainly inactivating p53 and its downstream pathway, and further indorse NGFR as a potential target for developing an anti-MIC agent useful for therapy against malignant and drug-resistant melanoma. Here, NGFR is linked to melanoma.